Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks to Buy with the Highest Upside Potential. On September 10, Gil Blum from Needham reiterated a Buy rating on Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) with a price target of $8. The analyst noted that the company has formed solid partnerships with major pharmaceutical companies, which are increasingly relying on TechBio companies like Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) for AI and machine learning expertise. He noted ...